84 related articles for article (PubMed ID: 19185840)
21. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
22. The IL-17/IL-23 axis of inflammation in cancer: friend or foe?
Martin-Orozco N; Dong C
Curr Opin Investig Drugs; 2009 Jun; 10(6):543-9. PubMed ID: 19513943
[TBL] [Abstract][Full Text] [Related]
23. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
[TBL] [Abstract][Full Text] [Related]
24. Regulatory T-cells in periapical lesions.
Colić M; Gazivoda D; Vucević D; Majstorović I; Vasilijić S; Rudolf R; Brkić Z; Milosavljević P
J Dent Res; 2009 Nov; 88(11):997-1002. PubMed ID: 19828886
[TBL] [Abstract][Full Text] [Related]
25. Cancer related inflammation: the macrophage connection.
Sica A; Allavena P; Mantovani A
Cancer Lett; 2008 Aug; 267(2):204-15. PubMed ID: 18448242
[TBL] [Abstract][Full Text] [Related]
26. IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway.
Ben Ahmed M; Belhadj Hmida N; Moes N; Buyse S; Abdeladhim M; Louzir H; Cerf-Bensussan N
J Immunol; 2009 Jun; 182(11):6763-70. PubMed ID: 19454671
[TBL] [Abstract][Full Text] [Related]
27. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
[TBL] [Abstract][Full Text] [Related]
28. Th17 in sensitized human lymphocytes ex vivo?
Haefner J; Krieg C; Michel I; Weisser H; Friedrich KH; Diel F
Inflamm Res; 2009 Apr; 58 Suppl 1():75-6. PubMed ID: 19271136
[No Abstract] [Full Text] [Related]
29. Protumor vs antitumor functions of IL-17.
Murugaiyan G; Saha B
J Immunol; 2009 Oct; 183(7):4169-75. PubMed ID: 19767566
[TBL] [Abstract][Full Text] [Related]
30. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells.
Ge W; Ma X; Li X; Wang Y; Li C; Meng H; Liu X; Yu Z; You S; Qiu L
Leuk Res; 2009 Jul; 33(7):948-57. PubMed ID: 19233469
[TBL] [Abstract][Full Text] [Related]
31. A link between the interleukin-6/Stat3 anti-apoptotic pathway and microRNA-21 in preimplantation mouse embryos.
Shen XH; Han YJ; Zhang DX; Cui XS; Kim NH
Mol Reprod Dev; 2009 Sep; 76(9):854-62. PubMed ID: 19437447
[TBL] [Abstract][Full Text] [Related]
32. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
33. IL-21 and IL-10 have redundant roles but differential capacities at different stages of Plasma Cell generation from human Germinal Center B cells.
Yoon SO; Zhang X; Berner P; Choi YS
J Leukoc Biol; 2009 Dec; 86(6):1311-8. PubMed ID: 19762555
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease.
Brereton CF; Sutton CE; Lalor SJ; Lavelle EC; Mills KH
J Immunol; 2009 Aug; 183(3):1715-23. PubMed ID: 19570828
[TBL] [Abstract][Full Text] [Related]
35. IL-1beta and IL-2 convert human Treg into T(H)17 cells.
Deknuydt F; Bioley G; Valmori D; Ayyoub M
Clin Immunol; 2009 May; 131(2):298-307. PubMed ID: 19211307
[TBL] [Abstract][Full Text] [Related]
36. A balance of interleukin-12 and -23 in cancer.
Ngiow SF; Teng MW; Smyth MJ
Trends Immunol; 2013 Nov; 34(11):548-55. PubMed ID: 23954142
[TBL] [Abstract][Full Text] [Related]
37. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.
Yu H; Kortylewski M; Pardoll D
Nat Rev Immunol; 2007 Jan; 7(1):41-51. PubMed ID: 17186030
[TBL] [Abstract][Full Text] [Related]
38. STAT3: A key signaling molecule for converting cold to hot tumors.
Hu R; Han Q; Zhang J
Cancer Lett; 2020 Oct; 489():29-40. PubMed ID: 32522692
[TBL] [Abstract][Full Text] [Related]
39. Role of Stat3 in suppressing anti-tumor immunity.
Kortylewski M; Yu H
Curr Opin Immunol; 2008 Apr; 20(2):228-33. PubMed ID: 18479894
[TBL] [Abstract][Full Text] [Related]
40. Statins, leptin and regulatory T cells.
Goldstein MR; Mascitelli L; Pezzetta F
Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):e27. PubMed ID: 18450434
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
